{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:35:18Z","timestamp":1758893718933,"version":"3.40.5"},"posted":{"date-parts":[[2023,10,4]]},"group-title":"In Review","reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,17]]},"abstract":"<title>Abstract<\/title>\n        <p>Although effective initially, prolonged androgen deprivation therapy (ADT) promotes neuroendocrine differentiation (NED) and prostate cancer (PCa) progression. It is incompletely understood how ADT transcriptionally induces NE genes in PCa cells. CREB1 and REST are known to positively and negatively regulate neuronal gene expression in the brain, respectively. No direct link between these two master neuronal regulators has been elucidated in the NED of PCa. We show that REST mRNA is downregulated in NEPC cell and mouse models, as well as in patient samples. Phenotypically, REST overexpression increases ADT sensitivity, represses NE genes, inhibits colony formation in culture, and xenograft tumor growth of PCa cells. As expected, ADT downregulates REST in PCa cells in culture and in mouse xenografts. Interestingly, CREB1 signaling represses REST expression. In studying the largely unclear mechanism underlying transcriptional repression of REST by ADT, we found that REST is a direct target of EZH2 epigenetic repression. Finally, genetic rescue experiments demonstrated that ADT induces NED through EZH2\u2019s repression of REST, which is enhanced by ADT-activated CREB signaling. In summary, our study has revealed a key pathway underlying NE gene upregulation by ADT, as well as established novel relationships between CREB1 and REST, and between EZH2 and REST, which may also have implications in other cancer types and in neurobiology.<\/p>","DOI":"10.21203\/rs.3.rs-3270539\/v1","type":"posted-content","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T16:16:52Z","timestamp":1696436212000},"source":"Crossref","is-referenced-by-count":2,"title":["Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1\/EZH2-mediated downregulation of REST"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-4347","authenticated-orcid":false,"given":"Wenliang","family":"Li","sequence":"first","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Integrated Hospital of Traditional Chinese Medicine, Southern Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukjin","family":"Yang","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Su","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bakhoum","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Sixth People's Hospital, Shanghai Jiaotong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0703-2334","authenticated-orcid":false,"given":"Samira","family":"Naderinezhad","sequence":"additional","affiliation":[{"name":"Brown Foundation Institute of Molecular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengmei","family":"Mao","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-9415","authenticated-orcid":false,"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"R35-r50","DOI":"10.1530\/ERC-19-0420","article-title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","volume":"27","author":"Davies A","year":"2020","unstructured":"Davies, A., Zoubeidi, A. & Selth, L.A. The epigenetic and transcriptional landscape of neuroendocrine prostate cancer. Endocrine-related cancer 27, R35-r50 (2020).","journal-title":"Endocrine-related cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga A","year":"2020","unstructured":"Quintanal-Villalonga, A., Chan, J.M., Yu, H.A., Pe'er, D., Sawyers, C.L., Sen, T. & Rudin, C.M. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat Rev Clin Oncol 17, 360\u2013371 (2020).","journal-title":"Nat Rev Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies AH","year":"2018","unstructured":"Davies, A.H., Beltran, H. & Zoubeidi, A. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. Nat Rev Urol 15, 271\u2013286 (2018).","journal-title":"Nat Rev Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/2159-8290.CD-11-0259","article-title":"Understanding the lethal variant of prostate cancer: power of examining extremes","volume":"1","author":"Aparicio A","year":"2011","unstructured":"Aparicio, A., Logothetis, C.J. & Maity, S.N. Understanding the lethal variant of prostate cancer: power of examining extremes. Cancer discovery 1, 466\u2013468 (2011).","journal-title":"Cancer discovery"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran H","year":"2014","unstructured":"Beltran, H., Tomlins, S., Aparicio, A., Arora, V., Rickman, D., Ayala, G., Huang, J., True, L., Gleave, M.E., Soule, H., Logothetis, C. & Rubin, M.A. Aggressive variants of castration-resistant prostate cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 20, 2846\u20132850 (2014).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study","volume":"36","author":"Aggarwal R","year":"2018","unstructured":"Aggarwal, R., Huang, J., Alumkal, J.J., Zhang, L., Feng, F.Y., Thomas, G.V., Weinstein, A.S., Friedl, V., Zhang, C., Witte, O.N., Lloyd, P., Gleave, M., Evans, C.P., Youngren, J., Beer, T.M., Rettig, M., Wong, C.K., True, L., Foye, A., Playdle, D., Ryan, C.J., Lara, P., Chi, K.N., Uzunangelov, V., Sokolov, A., Newton, Y., Beltran, H., Demichelis, F., Rubin, M.A., Stuart, J.M. & Small, E.J. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol 36, 2492\u20132503 (2018).","journal-title":"J Clin Oncol"},{"key":"ref7","first-page":"9","article-title":"Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies","author":"Puca L","year":"2019","unstructured":"Puca, L., Vlachostergios, P.J. & Beltran, H. Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies. Cold Spring Harbor perspectives in medicine 9 (2019).","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040692","article-title":"Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression","volume":"13","author":"Kaarijarvi R","year":"2021","unstructured":"Kaarijarvi, R., Kaljunen, H. & Ketola, K. Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression. Cancers 13 (2021).","journal-title":"Cancers"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e386-389","DOI":"10.1200\/JCO.2011.41.5166","article-title":"Challenges in recognizing treatment-related neuroendocrine prostate cancer","volume":"30","author":"Beltran H","year":"2012","unstructured":"Beltran, H., Tagawa, S.T., Park, K., MacDonald, T., Milowsky, M.I., Mosquera, J.M., Rubin, M.A. & Nanus, D.M. Challenges in recognizing treatment-related neuroendocrine prostate cancer. J Clin Oncol 30, e386-389 (2012).","journal-title":"J Clin Oncol"},{"year":"2004","author":"Hirano D","key":"ref10","unstructured":"Hirano, D., Okada, Y., Minei, S., Takimoto, Y. & Nemoto, N. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol 45, 586\u2013592; discussion 592 (2004)."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2002.12.065","article-title":"Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate","volume":"20","author":"Papandreou CN","year":"2002","unstructured":"Papandreou, C.N., Daliani, D.D., Thall, P.F., Tu, S.M., Wang, X., Reyes, A., Troncoso, P. & Logothetis, C.J. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20, 3072\u20133080 (2002).","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1093\/nar\/gkq604","article-title":"A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation","volume":"38","author":"Laneve P","year":"2010","unstructured":"Laneve, P., Gioia, U., Andriotto, A., Moretti, F., Bozzoni, I. & Caffarelli, E. A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res 38, 6895\u20136905 (2010).","journal-title":"Nucleic Acids Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4161\/cc.9.22.13973","article-title":"REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions","volume":"9","author":"Qureshi IA","year":"2010","unstructured":"Qureshi, I.A., Gokhan, S. & Mehler, M.F. REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions. Cell Cycle 9, 4477\u20134486 (2010).","journal-title":"Cell Cycle"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/gb-2006-7-9-r85","article-title":"Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression","volume":"7","author":"Wu J","year":"2006","unstructured":"Wu, J. & Xie, X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 7, R85 (2006).","journal-title":"Genome Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tcb.2013.01.006","article-title":"REST: an oncogene or a tumor suppressor?","volume":"23","author":"Negrini S","year":"2013","unstructured":"Negrini, S., Prada, I., D'Alessandro, R. & Meldolesi, J. REST: an oncogene or a tumor suppressor? Trends Cell Biol 23, 289\u2013295 (2013).","journal-title":"Trends Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yexcr.2013.09.020","article-title":"Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b ~ 25","volume":"320","author":"Liang H","year":"2014","unstructured":"Liang, H., Studach, L., Hullinger, R.L., Xie, J. & Andrisani, O.M. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b ~ 25. Exp Cell Res 320, 188\u2013199 (2014).","journal-title":"Exp Cell Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/nar\/gkt921","article-title":"Flores-Morales, A. REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer","volume":"42","author":"Svensson C","year":"2014","unstructured":"Svensson, C., Ceder, J., Iglesias-Gato, D., Chuan, Y.C., Pang, S.T., Bjartell, A., Martinez, R.M., Bott, L., Helczynski, L., Ulmert, D., Wang, Y., Niu, Y., Collins, C. & Flores-Morales, A. REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. Nucleic Acids Res 42, 999\u20131015 (2014).","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"26137","DOI":"10.18632\/oncotarget.8433","article-title":"REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling","volume":"7","author":"Lin TP","year":"2016","unstructured":"Lin, T.P., Chang, Y.T., Lee, S.Y., Campbell, M., Wang, T.C., Shen, S.H., Chung, H.J., Chang, Y.H., Chiu, A.W., Pan, C.C., Lin, C.H., Chu, C.Y., Kung, H.J., Cheng, C.Y. & Chang, P.C. REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling. Oncotarget 7, 26137\u201326151 (2016).","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"42795","DOI":"10.1038\/srep42795","article-title":"REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer","volume":"7","author":"Chang YT","year":"2017","unstructured":"Chang, Y.T., Lin, T.P., Campbell, M., Pan, C.C., Lee, S.H., Lee, H.C., Yang, M.H., Kung, H.J. & Chang, P.C. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep 7, 42795 (2017).","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1038\/s41467-018-06177-2","article-title":"Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers","volume":"9","author":"Zhang Y","year":"2018","unstructured":"Zhang, Y., Zheng, D., Zhou, T., Song, H., Hulsurkar, M., Su, N., Liu, Y., Wang, Z., Shao, L., Ittmann, M., Gleave, M., Han, H., Xu, F., Liao, W., Wang, H. & Li, W. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nature communications 9, 4080 (2018).","journal-title":"Nature communications"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1158\/0008-5472.CAN-08-2229","article-title":"Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression","volume":"68","author":"Deng X","year":"2008","unstructured":"Deng, X., Liu, H., Huang, J., Cheng, L., Keller, E.T., Parsons, S.J. & Hu, C.D. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res 68, 9663\u20139670 (2008).","journal-title":"Cancer Res"},{"key":"ref22","first-page":"850","article-title":"Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells","volume":"4","author":"Suarez CD","year":"2014","unstructured":"Suarez, C.D., Deng, X. & Hu, C.D. Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells. American journal of cancer research 4, 850\u2013861 (2014).","journal-title":"American journal of cancer research"},{"key":"ref23","first-page":"90","article-title":"Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure","volume":"5","author":"Hu CD","year":"2015","unstructured":"Hu, C.D., Choo, R. & Huang, J. Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure. Front Oncol 5, 90 (2015).","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer","volume":"27","author":"Cao Q","year":"2008","unstructured":"Cao, Q., Yu, J., Dhanasekaran, S.M., Kim, J.H., Mani, R.S., Tomlins, S.A., Mehra, R., Laxman, B., Cao, X., Yu, J., Kleer, C.G., Varambally, S. & Chinnaiyan, A.M. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27, 7274\u20137284 (2008).","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1118947","article-title":"Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3","volume":"310","author":"Cha TL","year":"2005","unstructured":"Cha, T.L., Zhou, B.P., Xia, W., Wu, Y., Yang, C.C., Chen, C.T., Ping, B., Otte, A.P. & Hung, M.C. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310, 306\u2013310 (2005).","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1073\/pnas.1000031107","article-title":"H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis","volume":"107","author":"Wang L","year":"2010","unstructured":"Wang, L., Jin, Q., Lee, J.E., Su, I.H. & Ge, K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 107, 7317\u20137322 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","article-title":"Regulation and Role of EZH2 in Cancer","volume":"46","author":"Yamaguchi H","year":"2014","unstructured":"Yamaguchi, H. & Hung, M.C. Regulation and Role of EZH2 in Cancer. Cancer Res Treat 46, 209\u2013222 (2014).","journal-title":"Cancer Res Treat"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao R","year":"2002","unstructured":"Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S. & Zhang, Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039\u20131043 (2002).","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon JA","year":"2008","unstructured":"Simon, J.A. & Lange, C.A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647, 21\u201329 (2008).","journal-title":"Mutat Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vire E","year":"2006","unstructured":"Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y. & Fuks, F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871\u2013874 (2006).","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10555-012-9387-3","article-title":"EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis","volume":"31","author":"Crea F","year":"2012","unstructured":"Crea, F., Fornaro, L., Bocci, G., Sun, L., Farrar, W.L., Falcone, A. & Danesi, R. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis. Cancer Metastasis Rev 31, 753\u2013761 (2012).","journal-title":"Cancer Metastasis Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2","volume":"69","author":"Friedman JM","year":"2009","unstructured":"Friedman, J.M., Liang, G., Liu, C.C., Wolff, E.M., Tsai, Y.C., Ye, W., Zhou, X. & Jones, P.A. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69, 2623\u20132629 (2009).","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2012.08.003","article-title":"Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells","volume":"78","author":"Kikuchi J","year":"2012","unstructured":"Kikuchi, J., Takashina, T., Kinoshita, I., Kikuchi, E., Shimizu, Y., Sakakibara-Konishi, J., Oizumi, S., Marquez, V.E., Nishimura, M. & Dosaka-Akita, H. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 78, 138\u2013143 (2012).","journal-title":"Lung Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.celrep.2012.12.020","article-title":"Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2","volume":"3","author":"Pal B","year":"2013","unstructured":"Pal, B., Bouras, T., Shi, W., Vaillant, F., Sheridan, J.M., Fu, N., Breslin, K., Jiang, K., Ritchie, M.E., Young, M., Lindeman, G.J., Smyth, G.K. & Visvader, J.E. Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell reports 3, 411\u2013426 (2013).","journal-title":"Cell reports"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e30393","DOI":"10.1371\/journal.pone.0030393","article-title":"The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells","volume":"7","author":"Shin YJ","year":"2012","unstructured":"Shin, Y.J. & Kim, J.H. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PloS one 7, e30393 (2012).","journal-title":"PloS one"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally S","year":"2008","unstructured":"Varambally, S., Cao, Q., Mani, R.S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., Brenner, J.C., Yu, J., Kim, J.H., Han, B., Tan, P., Kumar-Sinha, C., Lonigro, R.J., Palanisamy, N., Maher, C.A. & Chinnaiyan, A.M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322, 1695\u20131699 (2008).","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12094-012-0897-9","article-title":"Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics","volume":"15","author":"Wan L","year":"2013","unstructured":"Wan, L., Li, X., Shen, H. & Bai, X. Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics. Clin Transl Oncol 15, 132\u2013138 (2013).","journal-title":"Clin Transl Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13238-013-2093-2","article-title":"EZH2, an epigenetic driver of prostate cancer","volume":"4","author":"Yang YA","year":"2013","unstructured":"Yang, Y.A. & Yu, J. EZH2, an epigenetic driver of prostate cancer. Protein & cell 4, 331\u2013341 (2013).","journal-title":"Protein & cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran H","year":"2016","unstructured":"Beltran, H., Prandi, D., Mosquera, J.M., Benelli, M., Puca, L., Cyrta, J., Marotz, C., Giannopoulou, E., Chakravarthi, B.V., Varambally, S., Tomlins, S.A., Nanus, D.M., Tagawa, S.T., Van Allen, E.M., Elemento, O., Sboner, A., Garraway, L.A., Rubin, M.A. & Demichelis, F. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nature medicine 22, 298\u2013305 (2016).","journal-title":"Nature medicine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku SY","year":"2017","unstructured":"Ku, S.Y., Rosario, S., Wang, Y., Mu, P., Seshadri, M., Goodrich, Z.W., Goodrich, M.M., Labbe, D.P., Gomez, E.C., Wang, J., Long, H.W., Xu, B., Brown, M., Loda, M., Sawyers, C.L., Ellis, L. & Goodrich, D.W. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355, 78\u201383 (2017).","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13148-015-0074-4","article-title":"Polycomb-mediated silencing in neuroendocrine prostate cancer","volume":"7","author":"Clermont PL","year":"2015","unstructured":"Clermont, P.L., Lin, D., Crea, F., Wu, R., Xue, H., Wang, Y., Thu, K.L., Lam, W.L., Collins, C.C., Wang, Y. & Helgason, C.D. Polycomb-mediated silencing in neuroendocrine prostate cancer. Clin Epigenetics 7, 40 (2015).","journal-title":"Clin Epigenetics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu K","year":"2012","unstructured":"Xu, K., Wu, Z.J., Groner, A.C., He, H.H., Cai, C., Lis, R.T., Wu, X., Stack, E.C., Loda, M., Liu, T., Xu, H., Cato, L., Thornton, J.E., Gregory, R.I., Morrissey, C., Vessella, R.L., Montironi, R., Magi-Galluzzi, C., Kantoff, P.W., Balk, S.P., Liu, X.S. & Brown, M. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338, 1465\u20131469 (2012).","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1101\/gr.131508.111","article-title":"Cooperation between Polycomb and androgen receptor during oncogenic transformation","volume":"22","author":"Zhao JC","year":"2012","unstructured":"Zhao, J.C., Yu, J., Runkle, C., Wu, L., Hu, M., Wu, D., Liu, J.S., Wang, Q., Qin, Z.S. & Yu, J. Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res 22, 322\u2013331 (2012).","journal-title":"Genome Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran H","year":"2011","unstructured":"Beltran, H., Rickman, D.S., Park, K., Chae, S.S., Sboner, A., MacDonald, T.Y., Wang, Y., Sheikh, K.L., Terry, S., Tagawa, S.T., Dhir, R., Nelson, J.B., de la Taille, A., Allory, Y., Gerstein, M.B., Perner, S., Pienta, K.J., Chinnaiyan, A.M., Wang, Y., Collins, C.C., Gleave, M.E., Demichelis, F., Nanus, D.M. & Rubin, M.A. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer discovery 1, 487\u2013495 (2011).","journal-title":"Cancer discovery"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1003671","DOI":"10.1371\/journal.pcbi.1003671","article-title":"Comparison of REST cistromes across human cell types reveals common and context-specific functions","volume":"10","author":"Rockowitz S","year":"2014","unstructured":"Rockowitz, S., Lien, W.H., Pedrosa, E., Wei, G., Lin, M., Zhao, K., Lachman, H.M., Fuchs, E. & Zheng, D. Comparison of REST cistromes across human cell types reveals common and context-specific functions. PLoS Comput Biol 10, e1003671 (2014).","journal-title":"PLoS Comput Biol"},{"year":"2019","author":"Erkek S","key":"ref46","unstructured":"Erkek, S., Johann, P.D., Finetti, M.A., Drosos, Y., Chou, H.C., Zapatka, M., Sturm, D., Jones, D.T.W., Korshunov, A., Rhyzova, M., Wolf, S., Mallm, J.P., Beck, K., Witt, O., Kulozik, A.E., Fruhwald, M.C., Northcott, P.A., Korbel, J.O., Lichter, P., Eils, R., Gajjar, A., Roberts, C.W.M., Williamson, D., Hasselblatt, M., Chavez, L., Pfister, S.M. & Kool, M. Comprehensive Analysis of Chromatin States in Atypical Teratoid\/Rhabdoid Tumor Identifies Diverging Roles for SWI\/SNF and Polycomb in Gene Regulation. Cancer cell 35, 95\u2013110 e118 (2019)."},{"year":"2019","author":"Qadeer ZA","key":"ref47","unstructured":"Qadeer, Z.A., Valle-Garcia, D., Hasson, D., Sun, Z., Cook, A., Nguyen, C., Soriano, A., Ma, A., Griffiths, L.M., Zeineldin, M., Filipescu, D., Jubierre, L., Chowdhury, A., Deevy, O., Chen, X., Finkelstein, D.B., Bahrami, A., Stewart, E., Federico, S., Gallego, S., Dekio, F., Fowkes, M., Meni, D., Maris, J.M., Weiss, W.A., Roberts, S.S., Cheung, N.V., Jin, J., Segura, M.F., Dyer, M.A. & Bernstein, E. ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures. Cancer cell 36, 512\u2013527 e519 (2019)."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1002494","DOI":"10.1371\/journal.pgen.1002494","article-title":"REST-mediated recruitment of polycomb repressor complexes in mammalian cells","volume":"8","author":"Dietrich N","year":"2012","unstructured":"Dietrich, N., Lerdrup, M., Landt, E., Agrawal-Singh, S., Bak, M., Tommerup, N., Rappsilber, J., Sodersten, E. & Hansen, K. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet 8, e1002494 (2012).","journal-title":"PLoS Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molcel.2013.12.005","article-title":"The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing","volume":"53","author":"Mozzetta C","year":"2014","unstructured":"Mozzetta, C., Pontis, J., Fritsch, L., Robin, P., Portoso, M., Proux, C., Margueron, R. & Ait-Si-Ali, S. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell 53, 277\u2013289 (2014).","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai MC","year":"2010","unstructured":"Tsai, M.C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi, Y., Segal, E. & Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689\u2013693 (2010).","journal-title":"Science"},{"year":"2018","author":"Lee SW","key":"ref51","unstructured":"Lee, S.W., Oh, Y.M., Lu, Y.L., Kim, W.K. & Yoo, A.S. MicroRNAs Overcome Cell Fate Barrier by Reducing EZH2-Controlled REST Stability during Neuronal Conversion of Human Adult Fibroblasts. Dev Cell 46, 73\u201384 e77 (2018)."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-11-1867","article-title":"Modeling a lethal prostate cancer variant with small-cell carcinoma features","volume":"18","author":"Tzelepi V","year":"2012","unstructured":"Tzelepi, V., Zhang, J., Lu, J.F., Kleb, B., Wu, G., Wan, X., Hoang, A., Efstathiou, E., Sircar, K., Navone, N.M., Troncoso, P., Liang, S., Logothetis, C.J., Maity, S.N. & Aparicio, A.M. Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clinical cancer research: an official journal of the American Association for Cancer Research 18, 666\u2013677 (2012).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"year":"2019","author":"Abida W","key":"ref53","unstructured":"Abida, W., Cyrta, J., Heller, G., Prandi, D., Armenia, J., Coleman, I., Cieslik, M., Benelli, M., Robinson, D., Van Allen, E.M., Sboner, A., Fedrizzi, T., Mosquera, J.M., Robinson, B.D., De Sarkar, N., Kunju, L.P., Tomlins, S., Wu, Y.M., Nava Rodrigues, D., Loda, M., Gopalan, A., Reuter, V.E., Pritchard, C.C., Mateo, J., Bianchini, D., Miranda, S., Carreira, S., Rescigno, P., Filipenko, J., Vinson, J., Montgomery, R.B., Beltran, H., Heath, E.I., Scher, H.I., Kantoff, P.W., Taplin, M.E., Schultz, N., deBono, J.S., Demichelis, F., Nelson, P.S., Rubin, M.A., Chinnaiyan, A.M. & Sawyers, C.L. Genomic correlates of clinical outcome in advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 116, 11428\u201311436 (2019)."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai S","year":"2011","unstructured":"Tai, S., Sun, Y., Squires, J.M., Zhang, H., Oh, W.K., Liang, C.Z. & Huang, J. PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate 71, 1668\u20131679 (2011).","journal-title":"The Prostate"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2018.10.004","article-title":"Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer","volume":"440\u2013441","author":"Chen WY","year":"2019","unstructured":"Chen, W.Y., Zeng, T., Wen, Y.C., Yeh, H.L., Jiang, K.C., Chen, W.H., Zhang, Q., Huang, J. & Liu, Y.N. Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer. Cancer letters 440\u2013441, 35\u201346 (2019).","journal-title":"Cancer letters"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.molonc.2015.02.010","article-title":"Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells --> androgen receptor (AR) --> miRNA32 signals","volume":"9","author":"Dang Q","year":"2015","unstructured":"Dang, Q., Li, L., Xie, H., He, D., Chen, J., Song, W., Chang, L.S., Chang, H.C., Yeh, S. & Chang, C. Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells --> androgen receptor (AR) --> miRNA32 signals. Mol Oncol 9, 1241\u20131251 (2015).","journal-title":"Mol Oncol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2018.09.020","article-title":"ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis","volume":"439","author":"Niu Y","year":"2018","unstructured":"Niu, Y., Guo, C., Wen, S., Tian, J., Luo, J., Wang, K., Tian, H., Yeh, S. & Chang, C. ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis. Cancer letters 439, 47\u201355 (2018).","journal-title":"Cancer letters"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1677\/ERC-07-0061","article-title":"Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells","volume":"14","author":"Yuan TC","year":"2007","unstructured":"Yuan, T.C., Veeramani, S. & Lin, M.F. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocrine-related cancer 14, 531\u2013547 (2007).","journal-title":"Endocrine-related cancer"},{"key":"ref59","article-title":"GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells","author":"Sang M","year":"2016","unstructured":"Sang, M., Hulsurkar, M., Zhang, X., Song, H., Zheng, D., Zhang, Y., Li, M., Xu, J., Zhang, S., Ittmann, M. & Li, W. GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells. Oncotarget (2016).","journal-title":"Oncotarget"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/jm800710x","article-title":"Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor","volume":"51","author":"Graaf C","year":"2008","unstructured":"de Graaf, C. & Rognan, D. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor. J Med Chem 51, 4978\u20134985 (2008).","journal-title":"J Med Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa010819","article-title":"The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization","volume":"345","author":"Dishy V","year":"2001","unstructured":"Dishy, V., Sofowora, G.G., Xie, H.G., Kim, R.B., Byrne, D.W., Stein, C.M. & Wood, A.J. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. The New England journal of medicine 345, 1030\u20131035 (2001).","journal-title":"The New England journal of medicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1471-4159.1984.tb12757.x","article-title":"Forskolin stimulates adenylate cyclase activity, cyclic AMP accumulation, and adrenocorticotropin secretion from mouse anterior pituitary tumor cells","volume":"42","author":"Heisler S","year":"1984","unstructured":"Heisler, S. & Reisine, T. Forskolin stimulates adenylate cyclase activity, cyclic AMP accumulation, and adrenocorticotropin secretion from mouse anterior pituitary tumor cells. J Neurochem 42, 1659\u20131666 (1984).","journal-title":"J Neurochem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/MCB.20.12.4320-4327.2000","article-title":"Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo","volume":"20","author":"Du K","year":"2000","unstructured":"Du, K., Asahara, H., Jhala, U.S., Wagner, B.L. & Montminy, M. Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo. Molecular and cellular biology 20, 4320\u20134327 (2000).","journal-title":"Molecular and cellular biology"},{"key":"ref64","article-title":"SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition","author":"Li Y","year":"2016","unstructured":"Li, Y., Donmez, N., Sahinalp, C., Xie, N., Wang, Y., Xue, H., Mo, F., Beltran, H., Gleave, M., Wang, Y., Collins, C. & Dong, X. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. Eur Urol (2016).","journal-title":"Eur Urol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e1000979","DOI":"10.1371\/journal.pgen.1000979","article-title":"The transcription factor REST is lost in aggressive breast cancer","volume":"6","author":"Wagoner MP","year":"2010","unstructured":"Wagoner, M.P., Gunsalus, K.T., Schoenike, B., Richardson, A.L., Friedl, A. & Roopra, A. The transcription factor REST is lost in aggressive breast cancer. PLoS Genet 6, e1000979 (2010).","journal-title":"PLoS Genet"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature06780","article-title":"SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation","volume":"452","author":"Westbrook TF","year":"2008","unstructured":"Westbrook, T.F., Hu, G., Ang, X.L., Mulligan, P., Pavlova, N.N., Liang, A., Leng, Y., Maehr, R., Shi, Y., Harper, J.W. & Elledge, S.J. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452, 370\u2013374 (2008).","journal-title":"Nature"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1158\/1078-0432.CCR-15-0157","article-title":"SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer","volume":"21","author":"Zhang X","year":"2015","unstructured":"Zhang, X., Coleman, I.M., Brown, L.G., True, L.D., Kollath, L., Lucas, J.M., Lam, H.M., Dumpit, R., Corey, E., Chery, L., Lakely, B., Higano, C.S., Montgomery, B., Roudier, M., Lange, P.H., Nelson, P.S., Vessella, R.L. & Morrissey, C. SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 4698\u20134708 (2015).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu P","year":"2017","unstructured":"Mu, P., Zhang, Z., Benelli, M., Karthaus, W.R., Hoover, E., Chen, C.C., Wongvipat, J., Ku, S.Y., Gao, D., Cao, Z., Shah, N., Adams, E.J., Abida, W., Watson, P.A., Prandi, D., Huang, C.H., de Stanchina, E., Lowe, S.W., Ellis, L., Beltran, H., Rubin, M.A., Goodrich, D.W., Demichelis, F. & Sawyers, C.L. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84\u201388 (2017).","journal-title":"Science"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/onc.2016.319","article-title":"Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1","volume":"36","author":"Hulsurkar M","year":"2017","unstructured":"Hulsurkar, M., Li, Z., Zhang, Y., Li, X., Zheng, D. & Li, W. Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. Oncogene 36, 1525\u20131536 (2017).","journal-title":"Oncogene"},{"key":"ref70","first-page":"1627","article-title":"Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice","volume":"2","author":"Pettaway CA","year":"1996","unstructured":"Pettaway, C.A., Pathak, S., Greene, G., Ramirez, E., Wilson, M.R., Killion, J.J. & Fidler, I.J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clinical cancer research: an official journal of the American Association for Cancer Research 2, 1627\u20131636 (1996).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/erc.1.01043","article-title":"Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells","volume":"13","author":"Yuan TC","year":"2006","unstructured":"Yuan, T.C., Veeramani, S., Lin, F.F., Kondrikou, D., Zelivianski, S., Igawa, T., Karan, D., Batra, S.K. & Lin, M.F. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocrine-related cancer 13, 151\u2013167 (2006).","journal-title":"Endocrine-related cancer"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/15592294.2016.1146851","article-title":"Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas","volume":"11","author":"Kleb B","year":"2016","unstructured":"Kleb, B., Estecio, M.R., Zhang, J., Tzelepi, V., Chung, W., Jelinek, J., Navone, N.M., Tahir, S., Marquez, V.E., Issa, J.P., Maity, S. & Aparicio, A. Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics 11, 184\u2013193 (2016).","journal-title":"Epigenetics"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","article-title":"D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen","volume":"124","author":"Moffat J","year":"2006","unstructured":"Moffat, J., Grueneberg, D.A., Yang, X., Kim, S.Y., Kloepfer, A.M., Hinkle, G., Piqani, B., Eisenhaure, T.M., Luo, B., Grenier, J.K., Carpenter, A.E., Foo, S.Y., Stewart, S.A., Stockwell, B.R., Hacohen, N., Hahn, W.C., Lander, E.S., Sabatini, D.M. & Root, D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283\u20131298 (2006).","journal-title":"Cell"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nm.3968","article-title":"SWI\/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2","volume":"21","author":"Kim KH","year":"2015","unstructured":"Kim, K.H., Kim, W., Howard, T.P., Vazquez, F., Tsherniak, A., Wu, J.N., Wang, W., Haswell, J.R., Walensky, L.D., Hahn, W.C., Orkin, S.H. & Roberts, C.W. SWI\/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nature medicine 21, 1491\u20131496 (2015).","journal-title":"Nature medicine"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/sqb.2005.70.047","article-title":"Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells","volume":"70","author":"Pearlberg J","year":"2005","unstructured":"Pearlberg, J., Degot, S., Endege, W., Park, J., Davies, J., Gelfand, E., Sawyer, J., Conery, A., Doench, J., Li, W., Gonzalez, L., Boyce, F.M., Brizuela, L., Labaer, J., Grueneberg, D. & Harlow, E. Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells. Cold Spring Harb Symp Quant Biol 70, 449\u2013459 (2005).","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"ref76","article-title":"GRK3 is essential for metastatic cells and promotes prostate tumor progression","author":"Li W","year":"2014","unstructured":"Li, W., Ai, N., Wang, S., Bhattacharya, N., Vrbanac, V., Collins, M., Signoretti, S., Hu, Y., Boyce, F.M., Gravdal, K., Halvorsen, O.J., Nalwoga, H., Akslen, L.A., Harlow, E. & Watnick, R.S. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proceedings of the National Academy of Sciences of the United States of America (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41419-017-0161-x","article-title":"Mixed lineage kinase ZAK promotes epithelial-mesenchymal transition in cancer progression","volume":"9","author":"Li L","year":"2018","unstructured":"Li, L., Su, N., Zhou, T., Zheng, D., Wang, Z., Chen, H., Yuan, S. & Li, W. Mixed lineage kinase ZAK promotes epithelial-mesenchymal transition in cancer progression. Cell Death Dis 9, 143 (2018).","journal-title":"Cell Death Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neo.2021.09.005","article-title":"CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation","volume":"23","author":"Wang Z","year":"2021","unstructured":"Wang, Z., Hulsurkar, M., Zhuo, L., Xu, J., Yang, H., Naderinezhad, S., Wang, L., Zhang, G., Ai, N., Li, L., Chang, J.T., Zhang, S., Fazli, L., Creighton, C.J., Bai, F., Ittmann, M.M., Gleave, M.E. & Li, W. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia (New York, N.Y.) 23, 1147\u20131165 (2021).","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"Schultz, N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami E","year":"2012","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A.P., Sander, C. & Schultz, N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2, 401\u2013404 (2012).","journal-title":"Cancer discovery"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3270539\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3270539\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T13:22:46Z","timestamp":1698153766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3270539\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":79,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3270539\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,10,4]]},"subtype":"preprint"}}